Option Care Health (NASDAQ:OPCH) Releases Q4 2024 Earnings Guidance

Option Care Health (NASDAQ:OPCH) issued an update on its fourth quarter 2024 earnings guidance on Monday morning. The company provided earnings per share guidance of 0.420-0.450 for the period, compared to the consensus earnings per share estimate of 0.330. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.3 billion. Option Care Health also updated its FY 2024 guidance to 1.550-1.590 EPS.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. JMP Securities restated a “market outperform” rating and set a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research note on Friday. UBS Group started coverage on shares of Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price objective for the company. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. Truist Financial reduced their price objective on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Finally, Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $26.00 to $33.00 in a report on Monday. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $29.71.

Option Care Health Price Performance

OPCH stock opened at $27.72 on Tuesday. The company has a market cap of $4.72 billion, a price-to-earnings ratio of 23.29, a PEG ratio of 2.43 and a beta of 1.31. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The firm has a 50 day moving average of $23.20 and a 200-day moving average of $27.69. Option Care Health has a 12-month low of $21.39 and a 12-month high of $34.63.

Insider Buying and Selling at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of Option Care Health stock in a transaction dated Friday, November 8th. The shares were acquired at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares of the company’s stock, valued at $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 0.64% of the stock is owned by corporate insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.